Jeffrey William Henderson - Jul 11, 2023 Form 4 Insider Report for FIBROGEN INC (FGEN)

Role
Director
Signature
/s/ Cecelia Monoarfa-Taime, Attorney-in-fact
Stock symbol
FGEN
Transactions as of
Jul 11, 2023
Transactions value $
-$5,380
Form type
4
Date filed
7/13/2023, 08:28 PM
Previous filing
Jun 9, 2023
Next filing
Aug 8, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FGEN Common Stock Sale -$5.38K -2K -5.74% $2.69 32.9K Jul 11, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Shares sold by the reporting person pursuant to a 10b5-1 trading plan.
F2 Price reported is a weighted-average sales price. The shares were sold at prices ranging from $2.66 to $2.735. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.